Here Are Barron’s Best Income Investments for 2021

The bond market has been a barren field for income, as fixed-income yields remain stuck at historic lows. Yet there are rich pickings elsewhere—if you know where to look. “With rates just barely above all-time lows, yield opportunities are clustered in the equity markets,” says David King, co-manager of the Columbia Flexible Capital Income fund. […]

Continue Reading

Gene Munster Explains His Bullish Jumia Thesis

TipRanks 3 Big Dividend Stocks Yielding Over 7%; Raymond James Says ‘Buy’ Wall Street’s investment firms are burning the midnight oil as we approach the end of 2020, publishing their year-end notes and their New Year prognostications, both for investors’ edification. There is the obvious point: we’re in a moment of rising markets, and investor […]

Continue Reading

Weakness in XPeng Stock Is a Buying Opportunity

TipRanks 3 Big Dividend Stocks Yielding Over 7%; Raymond James Says ‘Buy’ Wall Street’s investment firms are burning the midnight oil as we approach the end of 2020, publishing their year-end notes and their New Year prognostications, both for investors’ edification. There is the obvious point: we’re in a moment of rising markets, and investor […]

Continue Reading

In the New Year, These 7 Value Stocks Deserve a Fresh Look

The new year promises changes on many fronts: economic, political, and public health, to name a few. It may also bring about a major shift in U.S. stock markets. A growing cadre of investors and strategists are betting that 2021 will finally be the year when value stocks outperform growth. Value has plenty of catching […]

Continue Reading

Dow Jones Gains As Schumer Offers McConnell Stimulus Bargain; Tesla Surges, Apple Falls

The Dow Jones Industrial Average rose as Senate Minority Leader Chuck Schumer attempted to strike a Covid-19 stimulus-check bargain with Republican rival Mitch McConnell. Meanwhile Apple (AAPL) stock slipped closer to a loss-taking zone, while EV stocks Tesla (TSLA) and Nio (NIO) surged higher. Intel (INTC) was the best-performing blue chip. X Schumer tried to […]

Continue Reading

Alibaba, Snap, Nikola: Upgrades and Downgrades

Stock analysts were busy in this final week of 2020 with downgrades and price-target changes. Downgrade Biopharma Arcturus Therapeutics  (ARCT) – Get Report saw its ratings cut by three analysts after a disappointing progress report on its coronavirus vaccine candidate. Barclays analyst Gena Wang slashed her rating to equal weight from overweight and lowered her price target […]

Continue Reading